Evaluation of the Abbott Architect, Roche Elecsys and Virtus S1 SARS-CoV-2 antibody tests in community-managed COVID-19 cases

Sebastian L. Johnston, Paul F McKay, Tatiana Kebadze, Kai Hu, Karnyart Samnuan, Juliya Aniscenko, Aoife Cameron, Neeta Patel, Paul Randell, Robin J Shattock, Michael R Edwards
doi: https://doi.org/10.1101/2020.10.27.20220509

Article usage

Article usage: October 2020 to November 2024

AbstractFullPdf
Oct 20208810199
Nov 2020436108176
Dec 2020218490147
Jan 2021206932161
Feb 2021243786114
Mar 2021248727127
Apr 2021156434204
May 2021162412197
Jun 2021125440161
Jul 2021128437131
Aug 202197367151
Sep 202189276163
Oct 202161214134
Nov 202171177124
Dec 2021596674
Jan 2022458843
Feb 202234119117
Mar 20222988107
Apr 2022253833
May 2022173123
Jun 202218712
Jul 202227711
Aug 2022261615
Sep 20223568
Oct 20222195
Nov 202221914
Dec 2022171024
Jan 202324410
Feb 202326815
Mar 20231775
Apr 202324214
May 202318211
Jun 20231296
Jul 20231446
Aug 2023241611
Sep 202319149
Oct 202320712
Nov 20231483
Dec 20232039
Jan 20242285
Feb 202435821
Mar 202486841
Apr 202451630
May 202484622
Jun 20242118
Jul 202413109
Aug 202422915
Sep 20242789
Oct 20241598
Nov 20241748
Back to top
Posted October 28, 2020.
Download PDF
Data/Code
Email
Evaluation of the Abbott Architect, Roche Elecsys and Virtus S1 SARS-CoV-2 antibody tests in community-managed COVID-19 cases
Sebastian L. Johnston, Paul F McKay, Tatiana Kebadze, Kai Hu, Karnyart Samnuan, Juliya Aniscenko, Aoife Cameron, Neeta Patel, Paul Randell, Robin J Shattock, Michael R Edwards
medRxiv 2020.10.27.20220509; doi: https://doi.org/10.1101/2020.10.27.20220509
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area